Results 51 to 60 of about 989 (171)

Effect of bilateral salpingectomy with hysterectomy on ovarian reserve [PDF]

, 2022
Background: Aim of the study was to evaluate the effect of salpingectomy with hysterectomy on ovarian reserve. Methods: This prospective case control study was done in the department of obstetrics and gynaecology from June 2020 to May 2021 on patients ...
Bhavana, Rudavath, Chaudhary, Rachna, Dhama, Vandana, Singh, Shakun   +3 more
core   +2 more sources

Ovarian reserve after salpingectomy: a systematic review and meta-analysis [PDF]

, 2017
Introduction Although there has been a growing concern over the possible damaging effect of salpingectomy on ovarian reserve, this issue remains uncertain.
Atalay, Atilgan, Broekmans, Chan, Fan, Findley, Golditch, Grynnerup, Hansen, Iwase, Johnson, Kwon, Lambert-Messerlian, Liberati, Mohamed, Morelli, Ni, Raffi, Rodgers, Sahin, Sahin Ersoy, Sezik, Song, Sumiala, Tone, Ulug, Venturella, Venturella, Ye   +28 more
core   +2 more sources

Efficiency of treatment and diagnostic algorithms in the rehabilitation program of women after hysterectomy with opportunist salpingectomy due to uterine myoma

Репродуктивная эндокринология, 2022
Objectives: to determine the effectiveness of the rehabilitation program in women of reproductive age with uterine fibroids for correction of genitourinary syndrome after hysterectomy with opportunistic salpingectomy. Materials and methods.
O.M. Proshchenko, I.B. Ventskivska
doaj   +1 more source

Ovarian cancer [PDF]

, 2016
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors, cells of origin, molecular compositions, clinical features and treatments.
A Bashashati, A Cassidy, A du Bois, A du Bois, A du Bois, A du Bois, A Gadducci, A Gnanasakthy, A Jemal, A Koushik, A Sokalska, A Varga, A Vazquez, A-M Patch, AA Ahmed, AA Tone, AD Santin, AJ Oswald, AL Jackson, AM Oza, AM Oza, AM Poveda, APM Finch, AR Mayer, B Kaufman, B Trabert, BA Goff, BA Goff, BE Howitt, BJ Monk, BJ Monk, BM Norquist, C Aghajanian, C Della Pepa, C Engel, C Lu, C Tian, CB Powell, CF Cheok, CJ Paller, CL Park, CL Pearce, CL Scott, CM Nagle, CM Olsen, Collaborative Group On Epidemiological Studies Of Ovarian Cancer, CP Crum, D Bell, D Callegaro-Filho, D Etemadmoghadam, D Hanahan, D Parkin, D Yang, DF Cella, DG Mutch, DK Armstrong, DM Eccles, DSP Tan, DW Kindelberger, E Basch, E Maritschnegg, E Pujade-Lauraine, E Pujade-Lauraine, E Zsiros, EA Calhoun, EMJJ Berns, F Medeiros, FS Hodi, G Coukos, G Ferrandina, G Liu, G Mangili, G Pentheroudakis, GJ Rustin, GJS Rustin, GL Ryland, H Falconer, H Kobayashi, HP Yang, I Hellström, I Romero, I Vergote, IA McNeish, IJ Jacobs, IJ Jacobs, J Brown, J Farley, J Hamanishi, J Kotsopoulos, J Ledermann, J Ledermann, J Liu, J Pfisterer, J Prat, J Walker, J Xie, JA Ledermann, JF Liu, JF Liu, JK Chan, JK Chan, JL Walker, JM Reyes-González, JN Bottsford-Miller, JN McAlpine, JS Hildebrand, JS Kwon, JW Carlson, K Alsop, K Basen-Engquist, K Gaitskell, K Schlienger, KA Donovan, KA Gelmon, KA Lowe, KC Wiegand, KL Bolton, KL Terry, KN Moore, KP Pennington, L McGowan, L Mei, L Wenzel, L Witkowski, L Wu, L Zhang, LH Castilla, LJ Havrilesky, LJ Havrilesky, LJ Havrilesky, LS Mørch, M Markman, M Markman, M Markman, M Sant, MA Bookman, MA Crispens, MA Merritt, MC Castells, MG Baratta, ML Disis, MR Stockler, MS Glickman, MS Piver, MS Piver, MS Rice, MW Audeh, N Katsumata, N Katsumata, N Keum, N Musrap, N Singh, N Suwaki, NR Gómez-Hidalgo, NS Horowitz, P Harter, P Jelinic, P-L Sung, PA Vasey, PG Moorman, PJ O'Donovan, R Perets, R Prakash, R Salani, RA Burger, RA Cannioto, RA Eeles, RD Alvarez, RE Bristow, RF Ozols, RGW Verhaak, RH Demir, RJ Kurman, RJ Kurman, RL Coleman, RL Siegel, RS Groen, RT Morris, RW Tothill, S Bentink, S Kehoe, S Mahner, S Pignata, S Pignata, S Zhang, S-J Baek, S-J Chang, S-J Chang, SA Cannistra, SA Narod, SC Houghton, SE Jensen, SK Sandhu, SM Domchek, SS Bassuk, SS Buys, T Al Rawahi, T Huang, T Walsh, TA Yap, TJ Herzog, TJ Herzog, TJ Perren, TM Friebel, TR Rebbeck, U Matulonis, U Menon, UA Matulonis, UA Matulonis, UA Matulonis, V Galic, V Jenkins, W Sakai, W-T Hwang, WA Cliby, WP McGuire, X Yang, Y Lee, Y Liu, Z Ketabi   +219 more
core   +1 more source

Opportunistic salpingectomy: an appropriate procedure during all pelvic surgeries [PDF]

American Journal of Obstetrics and Gynecology, 2019
(Am J Obstet Gynecol. 2019;220(1):10–11) Ovarian cancer is the deadliest gynecological disease in the United States, with 70% of patients presenting with late-stage III and IV disease. As there is no standard screening method for detecting early ovarian cancer, prevention has become an important goal.
Farr R, Nezhat, Vanessa T, Martinelli
openaire   +2 more sources

Patients' Perspectives on Opportunistic Salpingectomy at the Time of Nongynecologic Surgery. [PDF]

O G Open
OBJECTIVE: To identify barriers and facilitators from patients' perspectives for the implementation of opportunistic salpingectomy during nongynecologic surgeries. METHODS: This was a qualitative study based on individual in-depth interviews with patients (N=21) from six academic ...
Fisch C, Schauwaert J, Gootzen TA, Piek JMJ, de Reuver PR, Somford DM, Nienhuijs SW, de Hullu JA, Hermens RPMG.   +8 more
europepmc   +3 more sources

Opportunistic salpingectomy for prevention of sporadic ovarian cancer — a jump from basic science to clinical practice? [PDF]

, 2016
Ovarian cancer is the most malignant and aggressive gynecological cancer. Due to nonspecific symptoms in the early stage and a lack of effective screening methods, it is typically diagnosed at an advanced stage.
Bogusiewicz, Michał, Rechberger, Tomasz, Szumiło, Justyna, Ziętek, Alicja   +3 more
core   +2 more sources

A comparative study of the technical feasibility of complete salpingectomy versus tubal ligation as a method of tubal sterilisation during caesarean delivery [PDF]

, 2021
Background: Recent theory on ovarian malignancy suggests its origin from primary foci in fallopian tubes. Prophylactic salpingectomy may benefit in risk reduction of ovarian cancer.
Agarwal, Sunaina, Baruhee, Divya, Gupta, Taru   +2 more
core   +2 more sources

Short-term Effects of Opportunistic Salpingectomy on Ovarian Reserve: a Meta-analysis of Randomized Controlled Trials Based on GRADE Evidence Grading System [PDF]

Zhongguo quanke yixue
Background Opportunistic salpingectomy (OS) can be used as a primary prevention of ovarian cancer (OC) , but OS may cause impairment of ovarian function due to the homologous blood supply system shared by ovaries and fallopian tubes, thereby increasing ...
ZHAO Li, YANG Chunyan, ZUO Manyun, YANG Hongmei
doaj   +1 more source

Opportunistic Salpingectomy as an Ovarian Cancer Primary Prevention Strategy. [PDF]

J Obstet Gynaecol India, 2017
Ovarian cancer is the most lethal form of all gynecologic malignancies. The presenting clinical symptoms of ovarian cancer are very vague and often appear late in the course of disease. Hence, most patients are diagnosed at later stages. At present, there is no effective screening of ovarian cancer.
Balsarkar G.
europepmc   +4 more sources